Clinical Trials: Rabeprazole for Treatment of GERD in Pediatric Patients

Interventional

Study Type:

1-11 years (male/female)

Age/Gender Requirement:

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Sponsor:

The researchers conducting this study seek to assess “the effectiveness and safety of oral rabeprazole in the treatment of acid-related disorders in pediatric patients, focusing specifically on the manifestation of GERD (symptomatic and erosive types).”

To access this third-party resource, click here.

Purpose:

Rabeprazole for Treatment of GERD in Pediatric Patients